Essentials: Understanding & Healing the Mind | Dr. Karl Deisseroth
vor 10 Monaten
In this episode of Huberman Lab Essentials, my guest is Dr. Karl
Deisseroth, M.D., Ph.D., a clinical psychiatrist and professor of
bioengineering and of psychiatry and behavioral sciences at
Stanford University.
Podcast
Podcaster
Beschreibung
vor 10 Monaten
In this episode of Huberman Lab Essentials, my guest is Dr. Karl
Deisseroth, M.D., Ph.D., a clinical psychiatrist and professor of
bioengineering and of psychiatry and behavioral sciences at
Stanford University. We discuss his experiences as a clinician
treating complex psychiatric conditions and his lab’s pioneering
work in developing transformative therapies for mental illness. He
explains the complexities of mental illness and how emerging
technologies—such as optogenetics and brain-machine
interfaces—could revolutionize care. We also explore promising new
therapies, including psychedelics and MDMA, for conditions like
depression and PTSD. Read the episode show notes at
hubermanlab.com. Huberman Lab Essentials are short episodes focused
on essential science and protocol takeaways from past full-length
Huberman Lab episodes. Watch or listen to the full-length episode
at hubermanlab.com. Thank you to our sponsors AG1:
https://drinkag1.com/huberman David:
https://davidprotein.com/huberman Eight Sleep:
https://eightsleep.com/huberman Timestamps 00:00:00 Karl
Deisseroth; Neurology vs Psychiatry 00:01:36 Speech; Blood Test?;
Seeking Help 00:04:20 Feelings, Jargon; Psychiatric Treatment
00:09:40 Sponsor: David 00:10:55 Future Treatment; Vagus Nerve
Stimulation, Depression, Optogenetics 00:19:40 Brain-Machine
Interfaces 00:20:53 Sponsor: Eight Sleep 00:23:00 ADHD Symptoms,
Lifestyle, Technology 00:29:34 Psychedelics, Depression Treatment,
Risks 00:35:43 Sponsor: AG1 00:37:30 MDMA (Ecstasy), Trauma &
Post-Traumatic Stress Disorder (PTSD) Treatment 00:40:33
Projections: A Story of Human Emotions Book, Optimism Disclaimer
& Disclosures Learn more about your ad choices. Visit
megaphone.fm/adchoices
Deisseroth, M.D., Ph.D., a clinical psychiatrist and professor of
bioengineering and of psychiatry and behavioral sciences at
Stanford University. We discuss his experiences as a clinician
treating complex psychiatric conditions and his lab’s pioneering
work in developing transformative therapies for mental illness. He
explains the complexities of mental illness and how emerging
technologies—such as optogenetics and brain-machine
interfaces—could revolutionize care. We also explore promising new
therapies, including psychedelics and MDMA, for conditions like
depression and PTSD. Read the episode show notes at
hubermanlab.com. Huberman Lab Essentials are short episodes focused
on essential science and protocol takeaways from past full-length
Huberman Lab episodes. Watch or listen to the full-length episode
at hubermanlab.com. Thank you to our sponsors AG1:
https://drinkag1.com/huberman David:
https://davidprotein.com/huberman Eight Sleep:
https://eightsleep.com/huberman Timestamps 00:00:00 Karl
Deisseroth; Neurology vs Psychiatry 00:01:36 Speech; Blood Test?;
Seeking Help 00:04:20 Feelings, Jargon; Psychiatric Treatment
00:09:40 Sponsor: David 00:10:55 Future Treatment; Vagus Nerve
Stimulation, Depression, Optogenetics 00:19:40 Brain-Machine
Interfaces 00:20:53 Sponsor: Eight Sleep 00:23:00 ADHD Symptoms,
Lifestyle, Technology 00:29:34 Psychedelics, Depression Treatment,
Risks 00:35:43 Sponsor: AG1 00:37:30 MDMA (Ecstasy), Trauma &
Post-Traumatic Stress Disorder (PTSD) Treatment 00:40:33
Projections: A Story of Human Emotions Book, Optimism Disclaimer
& Disclosures Learn more about your ad choices. Visit
megaphone.fm/adchoices
Weitere Episoden
3 Stunden 16 Minuten
vor 3 Monaten
39 Minuten
vor 3 Monaten
2 Stunden 30 Minuten
vor 3 Monaten
41 Minuten
vor 3 Monaten
2 Stunden 14 Minuten
vor 4 Monaten
Abonnenten
Berlin
Kommentare (0)
Melde Dich an, um einen Kommentar zu schreiben.